Of note, a total of 19 non-adenocarcinoma patients harbored EGFR mutations, including 12 with squamous cell carcinoma, 4 with carcinoma not otherwise specified, 2 with mixed histology, and 1 with sarcomatoid carcinoma. Here, EGFR is linked to adenocarcinoma.